| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 10/04/2005 | US6951641 administering a dimeric nonionic X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering allergic conjunctivtis and allergic rhinitis |
| 10/04/2005 | CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g |
| 09/29/2005 | WO2005090340A1 Piperidine-1-carboxamide derivative |
| 09/29/2005 | WO2005090285A1 Novel crystal of triterpene derivative |
| 09/29/2005 | WO2005089714A1 Emulsion stabilizer |
| 09/29/2005 | WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 09/29/2005 | WO2004072037A8 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 09/29/2005 | US20050215640 HMB compositions and uses thereof |
| 09/29/2005 | US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole |
| 09/29/2005 | US20050215590 Formamide derivatives for the treatment of diseases |
| 09/29/2005 | US20050215582 Substituted pyrrolopyridines |
| 09/29/2005 | US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc |
| 09/29/2005 | US20050215549 TACE inhibitors |
| 09/29/2005 | US20050215547 Optically active pyridine derivative and a medicament containing the same |
| 09/29/2005 | US20050215534 Antiinflammatory agents; asthma; chronic obstructive pulmonary disease; dermatitis; antiallergens; antitumor agents; Aida; antiischemic agents; arrhythmia |
| 09/29/2005 | US20050215520 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
| 09/29/2005 | US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/29/2005 | US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens |
| 09/29/2005 | US20050214903 O-superfamily conotoxin peptides |
| 09/29/2005 | US20050214329 Vaccine |
| 09/29/2005 | US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock |
| 09/29/2005 | US20050214291 Treatment method |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214270 Lactobacillus acidophilus and/or fermentum; reducing immunoglobulin E levels; safe, easy to take |
| 09/29/2005 | US20050214228 Uniform powder production; controlling relative stream velocity, solution concentration and proportion of solvent to antisolvent; preventing liquid inclusion |
| 09/29/2005 | US20050214226 Spraying onto medium cooled below solidification temperature of expansion agent; creating surface ruptures; economic, simple, industrial scale; precise control of physical characteristics |
| 09/29/2005 | CA2562388A1 Emulsion-stabilized preparation |
| 09/29/2005 | CA2560767A1 Novel crystal of triterpene derivative |
| 09/29/2005 | CA2560157A1 New quaternized quinuclidine esters |
| 09/29/2005 | CA2559936A1 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 09/29/2005 | CA2559533A1 Phenylaminoethanol derivatives as beta2 receptor agonists |
| 09/29/2005 | CA2559196A1 Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents |
| 09/29/2005 | CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols |
| 09/28/2005 | EP1580188A1 Aryl ureas as kinase inhibitors |
| 09/28/2005 | EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 09/28/2005 | EP1579868A2 Use of IL-11 for treating various diseases |
| 09/28/2005 | EP1578917A2 Multimeric proteins and methods of making and using same |
| 09/28/2005 | EP1578897A2 Process for inducing functional tolerance to gene transfer products |
| 09/28/2005 | EP1411936B1 Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
| 09/28/2005 | EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 09/28/2005 | EP1361880B1 6-substituted pyrido-pyrimidines |
| 09/28/2005 | EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 09/28/2005 | EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1267905B1 Composition for the treatment of heart failure |
| 09/28/2005 | EP1225173B1 Naphthyridine derivatives |
| 09/28/2005 | EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 09/28/2005 | EP0832071B1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
| 09/28/2005 | CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines |
| 09/28/2005 | CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 09/28/2005 | CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/28/2005 | CN1675205A Novel quinuclidine derivatives and their use |
| 09/28/2005 | CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 09/28/2005 | CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 09/28/2005 | CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 09/28/2005 | CN1675189A Novel use of benzothiazole derivatives |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674939A Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674918A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
| 09/28/2005 | CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 09/28/2005 | CN1674910A Combination of azelastine and steroids |
| 09/28/2005 | CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections |
| 09/28/2005 | CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674887A Aerosol formulation for inhalation comprising an anticholinergic |
| 09/28/2005 | CN1674875A Anti-microbial compositions and methods of using same |
| 09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 09/28/2005 | CN1673231A Monoclonal antibody of SARS coronavirus N protein and its application |
| 09/28/2005 | CN1672731A Interferon spray for lung administration and its prepn process |
| 09/28/2005 | CN1672717A SARS preventing and treating Chinese medicine prepn |
| 09/28/2005 | CN1672716A Chinese medicine granule for preventing and treating respiratory tract infection |
| 09/28/2005 | CN1672703A Medicine xinqin tablet for treating allergic rhintis and its prepn |
| 09/28/2005 | CN1672681A Moxixacin capsule and its prepn process |
| 09/28/2005 | CN1672680A Stable moxixacin tablet and its prepn process |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220515C Medicine for treating throat disease |
| 09/28/2005 | CN1220511C Solid prepn. with functions of clearing and moistening throat, and its prodn. technique |
| 09/28/2005 | CN1220498C Medicament for treating asthma |
| 09/28/2005 | CN1220495C Traditional Chinese medicine for treating upper respiratory tract infection and its preparation method |
| 09/28/2005 | CN1220484C Microparticles for pulmonary administation |
| 09/28/2005 | CN1220451C 健康食品 Healthy Food |
| 09/27/2005 | US6949643 Thiazolopytimidines and their use as modulators of chemokine receptor activity |
| 09/27/2005 | US6949566 For use as metalloproteinase inhibitors |
| 09/27/2005 | US6949560 Imidazo-substituted compounds as p38 kinase inhibitors |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949546 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity |
| 09/27/2005 | US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 09/27/2005 | US6949541 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 09/27/2005 | US6949540 Substituted pyrazoles |
| 09/27/2005 | US6949539 Antiinflammatory agents; autoimmune disease; rheumatic disorders |
| 09/27/2005 | US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one |
| 09/27/2005 | US6949257 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders |
| 09/27/2005 | US6949133 Portable oxygen concentrator |
| 09/27/2005 | US6948494 improved entrainment/deep deposition into lungs; for treatment of asthma |
| 09/22/2005 | WO2005087925A1 Recombinant gene, disease animal model and method of evaluating test substance |
| 09/22/2005 | WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient |